Related Experiment Video
Updated: Jun 2, 2026

06:01
Expression of Transgenes in Native Bladder Urothelium Using Adenovirus-Mediated Transduction
Published on: October 6, 2022
Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target.
Peter Ochodnický1, Célia D Cruz, Naoki Yoshimura
1Department of Pharmacology and Pharmacotherapy, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. p.ochodnicky@amc.uva.nl
Neurourology and Urodynamics
|April 27, 2011
Summary
Nerve growth factor (NGF) plays a key role in bladder function and dysfunction. Targeting NGF shows promise for treating conditions like overactive bladder (OAB) and interstitial cystitis (IC/PBS).
Area of Science:
- Urology
- Neuroscience
- Molecular Biology
Background:
- Nerve growth factor (NGF) is a key regulator of neural plasticity in the micturition pathways.
- Initially known for its role in nerve development, NGF's function in the urinary bladder is increasingly recognized.
Purpose of the Study:
- To review experimental and clinical evidence on NGF's role in urinary bladder function and dysfunction.
- To explore NGF's involvement in conditions such as overactive bladder syndrome (OAB) and interstitial cystitis/painful bladder syndrome (IC/PBS).
Main Methods:
- Review of experimental studies involving NGF administration and its effects on bladder function.
- Analysis of clinical data on urinary NGF levels as diagnostic markers.
- Examination of rodent models of bladder dysfunction (e.g., bladder outlet obstruction, spinal cord injury, diabetic bladder dysfunction).
Main Results:
- Experimental NGF administration induces bladder overactivity symptoms, including urgency and hyperreflexia.
- Strong evidence links NGF to bladder dysfunction in various rodent models.
- Urinary NGF levels are being investigated as potential diagnostic markers for OAB and IC/PBS in humans.
Conclusions:
- NGF is a significant factor in urinary bladder pathophysiology, contributing to overactivity and pain syndromes.
- Therapeutic strategies targeting NGF, such as NGF sequestering proteins or antibodies, show potential for clinical application.
- Future research with advanced tools like transgenic mice and specific receptor modulators will further elucidate NGF's role in bladder disorders.
